Juan Andres
Director/Board Member bei AVANTOR, INC.
Vermögen: 1 Mio $ am 31.03.2024
Aktive Positionen von Juan Andres
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AVANTOR, INC. | Director/Board Member | 01.09.2019 | - |
| Independent Dir/Board Member | 01.09.2019 | - | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Karriereverlauf von Juan Andres
Ehemalige bekannte Positionen von Juan Andres
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EVELO BIOSCIENCES, INC. | Director/Board Member | 04.12.2019 | 20.11.2023 |
| Independent Dir/Board Member | 04.12.2019 | 20.11.2023 | |
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 01.08.2017 | 01.01.2023 |
| Corporate Officer/Principal | 01.01.2023 | 31.05.2023 | |
| NOVARTIS AG | Chief Tech/Sci/R&D Officer | 01.08.2005 | 01.06.2017 |
| Corporate Officer/Principal | - | - | |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.1987 | 01.01.2009 |
Ausbildung von Juan Andres
| Universida de Alcalá de Henares | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Schweiz | 2 |
| Spanien | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| NOVARTIS AG | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| AVANTOR, INC. | Process Industries |
| MODERNA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Juan Andres
- Erfahrung
